Suspension of Italian medtech price cuts upheld

05/14/2013 | Clinica

An Italian court ruling has upheld the suspension of a government mandate to cut prices for medical devices, invalidating the program that was scheduled to go into effect in January. The court found that the price cuts were based on a faulty use of the national medical device classification system and used inaccurate price sampling. Italian health care authorities must now come up with a different formula for implementing cost controls that recognizes the varied and specialized characteristics of the medtech sector.

View Full Article in:

Clinica

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Idaho Regional Director
PacificSource
Boise, ID
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA